Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Bioversys AG
BioCentury | Sep 12, 2024
Finance
Venture Report: Big rounds for Candid, Superluminal, PanTera
Plus: Rounds for Radiant, Vironexis, Bambusa, OrsoBio and F2G
BioCentury | May 9, 2024
Finance
Venture report: Big rounds for Bluejay, Attovia and Zenas
Strong fundraising week also included launches by Prologue and Commit, plus raises by Aardvark, Memo and OverT
BioCentury | Jun 9, 2022
Finance
June 8 Quick Takes: Fundings for Ariceum, Synklino, Anagenex and Biospring
Plus CureVac hiring Novartis’ Mendila, adding antigen discovery platform via Frame takeout, and updates from Aldeyra, Astellas, PineTree and more
BioCentury | May 6, 2022
Discovery & Translation
Sanofi and ModeX’s Epstein-Barr vaccine; plus San Raffaele, Walden and more
BioCentury’s roundup of translational news
BioCentury | May 19, 2021
Management Tracks
C-suite shake ups at Voyager, Passage; plus BioNTech, Iovance, Forbion, Aelix and more
Andre Turenne resigned as president and CEO of Voyager Therapeutics Inc. (NASDAQ:VYGR) and Omar Khwaja stepped down as the company’s CMO and head of research development to pursue other
BioCentury | Sep 3, 2020
Finance
Sept. 2 Quick Takes: Taysha files for IPO; plus DCVC’s Barclay joins Cohen’s Point72, Erasca, Deep Longevity and more
BioCentury | Oct 31, 2019
Preclinical News
Oct. 31 Preclinical Quick Takes: Beam licenses tech from Prime Medicine; plus BioVersys, Astellas-Kyoto University and more
Items per page:
1 - 10 of 14